Couple Finds Marriage Survives Surrogacy Journey
More Older Women Find Fulfillment Staying Single
Wegovy and Foundayo offer new weight-loss pill options with key
Woman’s unexpected breast cancer battle reshapes life and priorities
AI reshapes biopharma sales with smarter, data-driven engagement
Doctors rely on AI to bypass traditional source hierarchies
GLP-1 weight-loss drugs linked to sexual health changes

Roche drug outperforms existing lung cancer treatments

Doctors warn of rising health misinformation on social media

Processed foods can be nutritious-if chosen wisely

Diabetes Care Evolves Over Decades
argenx to buy Unnatural Products for $1.15bn
Veradermics reports positive Phase 3 hair loss results
Veradermics reported positive phase 3 results for its oral minoxidil product targeting mild-to-moderate pattern hair loss. The findings come from…
Quiet Quitting: How to Pull Back From a Toxic Mother
Protect your energy by setting boundaries with a toxic mother. Learn practical strategies for emotional well-being and pulling back from…
Seniors Challenge Myths, Adopt Better Sex in Later Life
Seniors challenge myths about sex in later life, adopting better sexual experiences. Discover how age can bring new passion.
New study links air pollution, UV, humidity to migraine risk
New study reveals air pollution, UV, and humidity may significantly increase migraine risk, especially in late spring and summer.
Private Telehealth Expands Access for Canadian Patients
Private telehealth expands access for Canadian patients as Dr. Hance Clarke’s Toronto clinic provides 60-70% of visits virtually, cutting hours…
New study tests direct switch from IVIG to subcutaneous efgartigimod
New phase 4 study explores direct switch from IVIG to subcutaneous efgartigimod for CIDP patients without disease worsening, presented at…
New International Study Monitors Nipocalimab Use in Pregnancy
FDA delays review of rare epilepsy drug
FDA approves first treatments for rare ataxia disorders

Clinicians Favor Peer Advice Over Pharma Messaging

Plasma exchange may slow aging process slightly

Unapproved Weight-Loss Drug Retatrutide Sold Illegally
Surgeon speaks out on mental health struggles
Cardiac surgeon Dr. Paul Fedak shares his mental health struggles and experiences as a leading surgeon in Calgary performing complex…
Over 100 Arthritis Types Categorized by Cause
Over 100 arthritis types, grouped by cause into degenerative, inflammatory, metabolic, and infectious categories, to understand joint conditions.
Breast cancer patient redefines treatment with control and curiosity
Brooke Gordon took control of her breast cancer treatment journey by embracing curiosity and proactive choices before symptoms appeared, redefining…
Latest News
Dermatology nurse helps patients beyond skin issues
Dermatology nurse helps patients with skin issues like eczema and psoriasis, affecting their confidence and daily life.
Diabetes Care Evolves Over Decades
Diabetes care has evolved from basic insulin injections in the 1960s to modern treatments, highlighting key advancements over…
Diet Key to Skin Health, Not Supplements Alone
A balanced diet, not supplements alone, is essential for optimal skin health and managing conditions like rashes or…
Canada to overhaul outdated cancer screening guidelines
Canada will overhaul outdated cancer screening guidelines that haven’t been updated in years, aiming to close gaps in…
No One Right Way to Feed Baby
Baby feeding choices with expert insights, recognizing there's no single right way to nourish your newborn effectively.
Immunovant Launches Phase 3 Trial for Myasthenia Gravis Drug
Immunovant launches phase 3 trial for myasthenia gravis drug, testing imeroprubart in adults with generalized myasthenia gravis (gMG).
Trappsol Cyclo trial misses primary goal, subgroup benefits
Trappsol Cyclo trial missed primary goal in Niemann-Pick disease, but subgroup benefits show signs of slowing disease progression…
New study tests direct switch from IVIG to subcutaneous efgartigimod
New phase 4 study explores direct switch from IVIG to subcutaneous efgartigimod for CIDP patients without disease worsening,…
New International Study Monitors Nipocalimab Use in Pregnancy
The PETUNIA study tracks nipocalimab pregnancy outcomes, monitoring pregnant people with myasthenia gravis, presented at the 2026 AANEM…
FDA grants priority review to Genentech’s MS drug
The FDA granted priority review to fenebrutinib multiple sclerosis drug, an experimental BTK inhibitor that may treat relapsing…